Sulfasalazine Market Size, Share & Trends Analysis Report By Product Type, By Application, By Distribution Channel, By Patient Demographics, By Disease Severity, By Prescription Type, By End-user, By Patient Education and Support, By Region, And By Segment Forecasts, 2025-2034
Sulfasalazine Market Size is valued at USD 2.2 Bn in 2024 and is predicted to reach USD 3.5 Bn by the year 2034 at a 5.0% CAGR during the forecast period for 2025-2034. Sulfasalazine, an anti-inflammatory drug, used to treat inflammatory gut diseases like Crohn's disease and ulcerative colitis. In the body, sulfasalazine aids in reducing inflammation. Sulfasalazine contains two active components: sulfapyridine and 5-aminosalicylic acid (5-ASA)...
Report ID: 2018 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
Peptide And Anticoagulant Drugs Market Size, Share & Trends Analysis Report by Peptide Drug Type (Antibiotic, Hormonal, Antifungal, ACE Inhibitor), Anticoagulant Drug Type (Heparin, Edoxaban, Apixaban, Dabigatran, Rivaroxaban), Administration Route (Oral, Injectable), By Peptide Application (Neurological Disorders, Metabolic Disorders, Gastrointestinal Disorders, Diabetes, Cancer, Cardiovascular Disorder, Infectious Diseases), Region And Segment Forecasts, 2025-2034
Peptide and Anticoagulant Drugs Market Size is predicted to develop with a 5.0% CAGR during the forecast period for 2025-2034. Blood thinners are anticoagulants, which are chemical agents that decrease blood coagulation and the time it takes for blood to clot. Anticoagulants are a type of medicine that is used to treat thrombotic disorders. Oral anticoagulants are available in pill, tablet, and injectable forms. Heparin is an injectable antico...
Report ID: 1837 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
Immune-Mediated Inflammatory Diseases Market Size, Share Detailed Report 2026 to 2035
Global Immune-Mediated Inflammatory Diseases Market Size is estimated to grow at a 7.10% CAGR during the forecast period for 2024 to 2031. Immune-Mediated Inflammatory Diseases Market Size, Share & Trends Analysis Report By Treatment Type (Traditional Drugs, Biologic Therapies, Novel Therapies), Indication (Asthma, Chronic Obstructive Pulmonary Diseases (COPD), Inflammatory Bowel Disease (IBD), Systemic Lupus Erythematosus (SLE), Rheumatoid ...
Report ID: 2889 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 165
Combination Vaccines Market Size, Share & Trends Analysis Report by Technology (Conjugate, Live, Inactivated), Age Group (Pediatric, Adult), Application (Diphtheria, Tetanus, & Pertussis (DTP), Polio, Hepatitis B, Influenza), End-use (Hospitals, Clinics) , Region And Segment Forecasts, 2025-2034
Global Combination Vaccines Market Size is valued at USD 5.2 Bn in 2024 and is predicted to reach USD 12.7 Bn by the year 2034 at a 9.6% CAGR during the forecast period for 2025-2034 The growth of the market for combination vaccines is being driven by an increase in the world's pediatric population. In addition, a different factor, such as the prevalence of infectious diseases, is favorably affecting market expansion. The frequency of viral dise...
Report ID: 1919 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
Nutraceutical Contract Manufacturing Services Market Size, Share & Trends Analysis Report By Dosage Form (Tablets, Capsules, Liquid Oral, Powder In Sachet /Jar, Gummies, Energy Bars), By Product (Dietary Supplements, Proteins & Amino Acids Supplements; Weight Management And Meal Replacer Supplements; Multivitamin, Multi-Mineral, And Antioxidant Supplements), By Region And Segment Forecasts, 2025-2034
Global Nutraceutical Contract Manufacturing Services Market Size is valued at USD 157.0 Bn in 2024 and is predicted to reach USD 414.4 Bn by the year 2034 at a 10.4% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: There is a rising consumer preference for preventive healthcare and natural remedies, leading to increased demand for a wide range of nutraceutical products. This trend is driving...
Report ID: 1780 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
PCOS Diagnostic Market Size, Share & Trends Analysis Report By Type (Pelvic Exam, Blood Test, Transvaginal Ultrasound), By End User (Hospitals & Clinics, Fertility Clinics, Others), By Region, And Segment Forecasts, 2024-2031
PCOS Diagnostic Market Size is predicted to witness a 5.0% CAGR during the forecast period for 2025-2034. PCOS (polycystic ovarian syndrome) is a hormonal condition affecting many women of reproductive age. PCOS is characterized by irregular or prolonged menstrual cycles as well as high levels of male hormones. Although there is no cure for PCOS, various medications are used to regulate the menstrual cycle and manage the condition's symptoms. ...
Report ID: 1758 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
Gastroesophageal Reflux Disease Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (Antacids, H2 Receptor Blockers, Proton Pump Inhibitors (PPIs), and Pro-Kinetic Agents), By Region, And Segment Forecasts, 2025-2034
Global Gastroesophageal Reflux Disease Therapeutics Market Size is valued at USD 4.9 Bn in 2021 and is predicted to reach USD 5.9 Bn by the year 2034 at a 1.9% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The demand for gastroesophageal reflux disease therapeutics is expected to rise due to the increasing number of initiatives by the government and non-governmental orga...
Report ID: 1705 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 180
Patient-Centered Medical Home Market Size, Share & Trends Analysis Report By Type (Health Detection, Care Service), By End-User (Nursing Homes, Home care Settings), By Region, And by Segment Forecasts, 2025-2034
Patient-Centered Medical Home Market Size is valued at USD 21.38 Billion in 2024 and is predicted to reach USD 83.87 Billion by the year 2034 at a 14.8% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Opportunities arise for health information technology (HIT) innovations to support the PCMH model. This patient-centered approach is a significant driver in healthcare transformation. Nort...
Report ID: 1438 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 178
Liver Disease Management Market Size, Share & Trends Analysis Report By Diagnosis (Endoscopy, Imaging, Biopsy, Others), By Treatment (Anti-Viral Drugs, Targeted Therapy, Chemotherapy, Others), By End-Use, By Region, And by Segment Forecasts, 2025-2034
Liver Disease Management Market Size is valued at USD 26.78 Billion in 2024 and is predicted to reach USD 52.28 Billion by the year 2034 at a 7.1% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The advent of the frequency of lifestyle-related liver diseases which are influenced by factors such as a sedentary lifestyle, poor diet, and alcohol consumption. Non-alcoholic fatty liver diseas...
Report ID: 1447 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 178
RNA Analysis Transcriptomics Market Size, Share & Trends Analysis Report By Type (Consumables, Instruments, Software, Services), By Application, By Technology (Microarrays, qPCR, Sequencing Technology), By Region, And By Segment Forecasts, 2025-2034
Global RNA Analysis Transcriptomics Market Size is valued at USD 13.0 Bn in 2024 and is predicted to reach USD 67.8 Bn by the year 2034 at an 18.2% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Expanding awareness of infectious diseases, decreasing sequencing costs, and growth in genomics in RNA transcripts are driving forces behind the market's expansion. RNA Transcriptome manufacturing...
Report ID: 1403 |
Delivery: Immediate |
Published: July 2025 |
No. of Pages: 175
Pharmaceuticals